Preoperative Endoscopic Pancreatic Stent for Distal Pancreatectomy
1 other identifier
interventional
56
1 country
1
Brief Summary
Distal pancreatectomy (DP) with or without splenectomy is commonly indicated for pancreatic body or tail lesions. Postoperative pancreatic fistula (POPF) remains the commonest complication after DP. A pre-operatively placed pancreatic stent across papilla can decrease the pressure gradient between pancreatic duct and duodenum. Therefore, the pancreatic juice flow is redirected from the pancreatic transection plane and leakage from pancreatic stump is much reduced. This study aims to evaluate whether pre-operatively placed pancreatic stent can prevent POPF by a randomized controlled trial.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Mar 2022
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 3, 2022
CompletedStudy Start
First participant enrolled
March 21, 2022
CompletedFirst Posted
Study publicly available on registry
March 28, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 20, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
May 20, 2026
ExpectedMarch 28, 2022
March 1, 2022
4 years
March 3, 2022
March 22, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Number of participants with postoperative pancreatic fistula
The number of participants developing post-operative pancreatic fistula, which is defined as drain fluid amylase more than 3 times the upper limit of the normal value of serum amylase on or after postoperative day 3
Day 3 after operation
Secondary Outcomes (4)
Number of participants developing post-operative morbidity
90 days
Number of participants developing post-operative mortality
90 days
Total length of hospital stay of participants
90 days after endoscopy and operation
Number of participants developing complications related to Endoscopic Retrograde Cholangiography
14 days after endoscopy
Study Arms (2)
Pre-op Stenting
EXPERIMENTALPre-operative pancreatic stent inserted by Endoscopic Retrograde Cholangiography, followed by distal pancreatectomy
Surgery alone
ACTIVE COMPARATORDistal pancreatectomy alone
Interventions
Pancreatic stent of appropriate size and length is inserted to the pancreatic duct before distal pancreatectomy
Eligibility Criteria
You may qualify if:
- Age \>18 years
- Elective distal pancreatectomy for primary pancreatic pathology
You may not qualify if:
- Informed consent not available
- Emergency distal pancreatectomy
- Presence of pancreatic duct stricture
- Presence of altered anatomy that precludes safe Endoscopic Retrograde Cholangiography (e.g. previous Billroth II gastrectomy)
- History of severe pancreatitis
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Prince of Wales Hospital
Hong Kong, Hong Kong
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Kit Fai Lee, MBBS
Clinical Associate Professor (honorary)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Clinical Associate Professor (honorary)
Study Record Dates
First Submitted
March 3, 2022
First Posted
March 28, 2022
Study Start
March 21, 2022
Primary Completion
March 20, 2026
Study Completion (Estimated)
May 20, 2026
Last Updated
March 28, 2022
Record last verified: 2022-03
Data Sharing
- IPD Sharing
- Will not share